News

Home/News
News 2017-06-21T13:15:59+00:00
October 13, 2017
Transgene: Peer Reviewed Scientific Publications Highlight TG4010’s Ability to Induce Broad CD8+ Responses and its Synergistic Effects in Combination with Immune Checkpoint Inhibitors
STRASBOURG, France -- (BUSINESS WIRE) -- Regulatory News: Transgene (TNG.PA), a biotech company that designs and develops viral-based immunotherapies, recently published two papers supporting the efficacy and ...
October 13, 2017
Mirati Therapeutics' Mocetinostat Included In Stand Up To Cancer's Cutting-Edge Clinical Trial Initiative For NSCLC Patients
SAN DIEGO, Oct. 12, 2017 /PRNewswire/ -- Mirati Therapeutics, Inc. (MRTX), a clinical stage oncology biotechnology company, announced today that the Company has been included in ...
October 13, 2017
Prometic Announces FDA Acceptance of its Biologics License Application for Plasminogen (Ryplazim™)
LAVAL, QC, Oct. 13, 2017 /PRNewswire/ - Prometic Life Sciences Inc. (PLI.TO) (PFSCF) (Prometic) today announced that the U.S Food and Drug Administration (FDA) has accepted ...
October 13, 2017
Rexahn Announces $8 Million Registered Direct Offering
ROCKVILLE, Md., Oct. 13, 2017 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American:RNN) today announced it has entered into definitive agreements with institutional investors to ...
October 13, 2017
BioTime, Inc. Announces Pricing of $25.0 Million Public Offering of Common Stock
ALAMEDA, Calif.--(BUSINESS WIRE)-- BioTime, Inc. (“BioTime”) (NYSE American and TASE: BTX), a late stage clinical biotechnology company focused on developing and commercializing products addressing degenerative ...
October 12, 2017
BioDelivery Sciences Announces Patent Litigation Settlement Agreement with Teva
RALEIGH, N.C., Oct. 12, 2017 /PRNewswire/ -- BioDelivery Sciences International, Inc. (BDSI), a specialty pharmaceutical company with a focus in pain management and addiction medicine, ...
October 12, 2017
Zealand has initiated a clinical trial to evaluate the potential for less than once-daily dosing with its long-acting GLP-2 analog glepaglutide
Copenhagen, Denmark, October 12, 2017 - Zealand Pharma announces dosing has started in a clinical trial with glepaglutide under an investigational new drug application (IND) ...
October 12, 2017
Soleno Therapeutics Receives Positive Opinion from European Orphan Committee for DCCR in Prader-Willi Syndrome
REDWOOD CITY, Calif., Oct. 12, 2017 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare ...
October 12, 2017
Acer Therapeutics Welcomes Two New Members to its Board of Directors
CAMBRIDGE, Mass., Oct. 12, 2017 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc., (ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for ...
October 11, 2017
BIOPHYTIS completes a €10.4 M capital increase to finance mid-stage clinical trials for two novel anti-aging drug-candidates
PARIS, Oct. 11, 2017 (GLOBE NEWSWIRE) -- BIOPHYTIS (Euronext Growth Paris:ALBPS), a biotechnology company specializing in the development of drug candidates to treat age-related diseases, ...
October 11, 2017
Sierra Oncology to Present at the 2017 BIO Investor Forum
VANCOUVER, Oct 11, 2017 /PRNewswire/ - Sierra Oncology, Inc. (SRRA), a clinical stage drug development company focused on advancing next generation DNA Damage Response (DDR) ...
October 11, 2017
BioTime and Processa Announce Their Intention to Enter into a HyStem® Sublicense for Drug Delivery
ALAMEDA, Calif. -- (BUSINESS WIRE) -- BioTime, Inc. (NYSE American: BTX), a late stage clinical biotechnology company focused on developing and commercializing products addressing degenerative diseases, ...
October 11, 2017
Marathon Asset Management and ADMA Biologics Complete $30 Million Debt Refinancing
RAMSEY, N.J., Oct. 11, 2017 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (ADMA) (“ADMA” or the “Company”), a vertically integrated commercial biopharmaceutical company that develops, manufactures ...
October 11, 2017
Soleno Therapeutics Announces Issuance of New U.S. Patent for DCCR Covering Treatment of Hyperphagia in Prader-Willi Syndrome
REDWOOD CITY, Calif., Oct. 11, 2017 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare ...
October 11, 2017
Ohr Pharmaceutical to Present at the Dawson James 3rd Annual Small Cap Growth Conference
NEW YORK, Oct. 11, 2017 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (OHRP), a clinical-stage pharmaceutical company developing novel therapies for ophthalmic diseases, today announced that ...
October 11, 2017
VBI Vaccines to Present at The World Vaccine Congress Europe 2017 in Barcelona
CAMBRIDGE, MASSACHUSETTS--(Marketwired - Oct 11, 2017) - VBI Vaccines Inc. (VBIV)(VBV.TO) (VBI) today announced that Adam Buckley, vice president of business development, will discuss VBI's ...
October 11, 2017
BioTime Announces First Patient in U.S. Clinical Trial Treated for Facial Volume Deficit
ALAMEDA, Calif.--  (BUSINESS WIRE) -- BioTime, Inc. (NYSE American: BTX), a late stage clinical biotechnology company focused on developing and commercializing products addressing degenerative diseases, today ...
October 10, 2017
Aradigm Regains Compliance with NASDAQ Listing Requirements
HAYWARD, Calif. -- (BUSINESS WIRE) -- Aradigm Corporation (ARDM) (“Aradigm" or the “Company”) today announced that it received notice from The NASDAQ Capital Market (“NASDAQ”) indicating ...
October 10, 2017
CytoSorbents to Present at the 2017 BIO Investor Forum
MONMOUTH JUNCTION, N.J., Oct. 10, 2017 /PRNewswire/ -- CytoSorbents Corporation(CTSO), a critical care immunotherapy leader using CytoSorb® blood purification to treat deadly inflammation in critically ...
October 10, 2017
Rexahn Pharmaceuticals Receives Positive Opinion from European Medicines Agency for Orphan Drug Designation for RX-3117
ROCKVILLE, Md., Oct. 10, 2017 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE AMERICAN:RNN), a clinical stage biopharmaceutical company developing innovative, targeted therapeutics for the treatment ...
Page 18 of 48